As someone who has lived with spinal muscular atrophy for all 30 years of my life, I was perplexed and disappointed that the recent approval of Novartis’ gene therapy Zolgensma was immediately overshadowed by outrage over the drug’s price: $2.125 million

Quick Read

Researchers, including our Matthew DeCamp, MD, PhD, are formalizing the evaluation of how Medicare Shared Savings Program Accountable Care Organizations report savings distribution and whether the evaluation has any effect on the success of that ACO

Quick Read

In principle, 34 states could restore subsidies by creating their own insurance exchanges. Political leaders will certainly come under intense pressure to do so, although time is short to get an exchange up and running for 2016. Given the potential need for swift action, do the states have contingency plans in place? Could they move quickly in the wake of an adverse decision?

Quick Read

All but one of the these facilities is owned by for-profit entities, and by far the largest number of hospitals — 20 — are in Florida

Quick Read

A new report from Health and Human Services finds that the uninsured rate has fallen from 20.3 percent prior to the health-care law down to 13.2 percent at the start of 2015. This is a 7.1 percentage-point decrease in the uninsured rate — or, to put it another way, a 35-percent decline in the number of Americans who lack insurance coverage

Quick Read

The ethical issues that come with crowdfunded healthcare. “If we use crowdsourcing for healthcare costs as a way to replace what a good healthcare system might do, then we’re really creating a new health disparity,” said Margaret Moon, a bioethicist and professor of pediatrics at Johns Hopkins Berman Institute of Bioethics

Quick Read

Q & A with Antônio Salazar P. Brandão, PhD, an Associate Professor in the Department of Economic Analysis at the State University of Rio de Janeiro and a participant in the Feeding the World, Ethically meeting

Read More